Report ID: SQMIG35H2315
Report ID:
SQMIG35H2315 |
Region:
Global |
Published Date: November, 2024
Pages:
194
|
Tables:
117 |
Figures:
78
Cell Viability Assays Market size was valued at USD 1.52 Billion in 2023 and is poised to grow from USD 1.67 Billion in 2024 to USD 3.56 Billion by 2032, growing at a CAGR of 9.94% during the forecast period (2025-2032).
Cell viability can be described as the presence of living or viable cells. It is considered as an indicator of good cell health. It is a viability stage that is modified because of an event of chemical or physical agents like in toxicity agents. Furthermore, cell viability assays (CVAs) are utilized for analyzing the cellular response to any pathogenic agent or drug. This is one of the reasons due to which it has found vast applications in the pharmaceutical and medical sector. the cell viability assays market is recently experiencing substantial growth due to the increasing emphasis on drug development. Cell viability assays play a vital part in early-stage drug discovery by allowing the evaluation of compound efficiency, toxicity, and safety profiles. This constant requirement for new drugs and the increasing pharma and biotechnology sectors are fueling the demand for cell viability assays market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2315